Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Myofascia of Chronic Low Back Pain Adults

Sponsor
Université de Sherbrooke (Other)
Overall Status
Recruiting
CT.gov ID
NCT04830566
Collaborator
(none)
48
1
2
4.4
10.8

Study Details

Study Description

Brief Summary

Non-specific low back pain is a worldwide health issue that remains poorly understood. Some authors have shown that the thoracolumbar fascia of low back pain adults presents changes in biomechanical properties. As it is richly endowed with pain receptors, the thoracolumbar fascia could therefore be a key contributor to this chronic pain condition. Myofascial techniques (MFTs) are commonly used in manual therapy by practitioners of various backgrounds to address fascia biomechanical properties, but there is a paucity of objective evidence on their effects on tissue state. Musculoskeletal ultrasonography, sonoelastography and myometry are emerging imaging techniques that can quantify the biomechanical properties of fascia and underlying muscle. These innovative techniques could in turn contribute to a better understanding of MFTs effects on fascial properties.

The main objective of this study is to evaluate the immediate effect of a standardized MFT on the elastography features of the lumbar paraspinal muscle and fascia (i.e. myofascial unit). The secondary objectives are to evaluate the immediate effects of a MFT on: i) ultrasonography features of the myofascial unit; ii) myometry features of the myofascial unit; ii) pain intensity.

Condition or Disease Intervention/Treatment Phase
  • Other: Myofascial release technique
  • Other: Simulated Myofascial Release technique
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Paraspinal Muscle and Thoracolumbar Fascia in Chronic Low Back Pain Adults Assessed by Elastography, Ultrasonography and Myometry
Actual Study Start Date :
Mar 19, 2021
Anticipated Primary Completion Date :
Aug 1, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Myofascial release technique group

Other: Myofascial release technique
Myofascial technique on the thoracolumbar fascia and lumbar paraspinal muscles

Sham Comparator: Simulated myofascial release technique group

Other: Simulated Myofascial Release technique
Superficial hands contact on the lumbar area

Outcome Measures

Primary Outcome Measures

  1. Changes in elastography features of the myofascial unit [Baseline (before treatment), post-treatment (immediately after treatment)]

    Evaluated with a shear wave sonoelastography device.

Secondary Outcome Measures

  1. Changes in ultrasonography features of the myofascial unit [Baseline (before treatment) post-treatment (immediately after treatment)]

    Evaluated with a B-mode ultrasound imaging device

  2. Changes in myometry features of the myofascial unit [Baseline (before treatment) post-treatment (immediately after treatment)]

    Evaluated with a myotonometer

  3. Changes in pain intensity [Baseline (before treatment) post-treatment (immediately after treatment), at day 2 and at day 7 after the intervention]

    Numeric rating Scale (0 to 10; minimum = 0; maximum = 10; higher score means worst outcome)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adults over 18 years of age,

  • lumbar pain and/or referred pain above or below the gluteal fold , with intensity > 3/10, persisting for > 6 months and presenting during the day > 50% of the time.

Exclusion Criteria:
  • history of serious spinal or lower extremity injury or surgery in the last year

  • identifiable back pain or known pathology

  • known rheumatological condition

  • oral or injectable corticosteroids in the lumbar spine within the last 3 months

  • psychiatric disorder

  • pregnancy

  • manual treatment of the lumbo-sacral region 1 month prior to the experimentation and during the week of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre de recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke Quebec Canada J1H 5N4

Sponsors and Collaborators

  • Université de Sherbrooke

Investigators

  • Study Director: Nathaly Gaudreault, PhD, Université de Sherbrooke
  • Study Director: Mélanie Morin, PhD, Université de Sherbrooke

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mélanie Morin, Research director, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT04830566
Other Study ID Numbers:
  • 2021-3572
First Posted:
Apr 5, 2021
Last Update Posted:
Apr 5, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mélanie Morin, Research director, Université de Sherbrooke
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2021